Hemophilia drug monitored in routine patients
NCT ID NCT02941783
Summary
This study monitored the safety and effectiveness of Kovaltry, a treatment for hemophilia A, in 230 patients during routine medical care in Japan. Researchers tracked side effects and how well the drug controlled bleeding episodes over two years. The goal was to gather real-world information after the drug was approved for use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.